These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2059 related articles for article (PubMed ID: 18163430)
21. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors. Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471 [TBL] [Abstract][Full Text] [Related]
22. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells. Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155 [TBL] [Abstract][Full Text] [Related]
23. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
24. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
25. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells. Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210 [TBL] [Abstract][Full Text] [Related]
26. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523 [TBL] [Abstract][Full Text] [Related]
27. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells. Lu S; Dong Z Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418 [TBL] [Abstract][Full Text] [Related]
28. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246 [TBL] [Abstract][Full Text] [Related]
29. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells. Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555 [TBL] [Abstract][Full Text] [Related]
30. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911 [TBL] [Abstract][Full Text] [Related]
31. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP. Koochekpour S; Lee TJ; Wang R; Sun Y; Delorme N; Hiraiwa M; Grabowski GA; Culig Z; Minokadeh A J Cell Biochem; 2007 Jun; 101(3):631-41. PubMed ID: 17171640 [TBL] [Abstract][Full Text] [Related]
32. Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells. Zhu B; Fukada K; Zhu H; Kyprianou N Cancer Res; 2006 Sep; 66(17):8640-7. PubMed ID: 16951178 [TBL] [Abstract][Full Text] [Related]
33. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1. Gerdes MJ; Larsen M; Dang TD; Ressler SJ; Tuxhorn JA; Rowley DR Prostate; 2004 Feb; 58(3):299-307. PubMed ID: 14743470 [TBL] [Abstract][Full Text] [Related]
34. Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells. Matsuda T; Junicho A; Yamamoto T; Kishi H; Korkmaz K; Saatcioglu F; Fuse H; Muraguchi A Biochem Biophys Res Commun; 2001 Apr; 283(1):179-87. PubMed ID: 11322786 [TBL] [Abstract][Full Text] [Related]
35. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. Wang LG; Ossowski L; Ferrari AC Cancer Res; 2001 Oct; 61(20):7544-51. PubMed ID: 11606392 [TBL] [Abstract][Full Text] [Related]
36. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus. Jia L; Coetzee GA Cancer Res; 2005 Sep; 65(17):8003-8. PubMed ID: 16140973 [TBL] [Abstract][Full Text] [Related]
37. Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Gnanapragasam VJ; Robson CN; Neal DE; Leung HY Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757 [TBL] [Abstract][Full Text] [Related]
38. Hypoxia increases androgen receptor activity in prostate cancer cells. Park SY; Kim YJ; Gao AC; Mohler JL; Onate SA; Hidalgo AA; Ip C; Park EM; Yoon SY; Park YM Cancer Res; 2006 May; 66(10):5121-9. PubMed ID: 16707435 [TBL] [Abstract][Full Text] [Related]
39. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line. Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738 [TBL] [Abstract][Full Text] [Related]
40. Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells. Rimler A; Lupowitz Z; Zisapel N Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():45-9. PubMed ID: 12019351 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]